An Advanced CME Live Course in HIV Pathogenesis, Antiretrovirals, and Other Selected Issues in HIV Disease Management
San Francisco, CA
Friday, May 2, 2014
8:00 AM – 3:45 PM
Assessment of Needs
Rapid advances in HIV disease management require the ongoing attention of practitioners involved in HIV medicine. This course will address the implications of new information on strategies for clinical management. Information will be presented through a mix of didactic lectures and clinically relevant cases developed by an expert faculty of HIV/AIDS clinicians and researchers.
Upon completion of the course, participants will be able to:
- Apply new data to the management of HIV with antiretroviral therapy
- Describe current data on preexposure prophylaxis to prevent HIV infection
- Discuss new approaches to research into curing HIV infection
- Determine which HIV-infected patients with hepatitis C virus (HCV) infection are candidates for HCV treatment with directly acting antivirals, design regimens and assessments of response, and describe drug interactions, especially in HIV/HCV coinfected patients on antiretroviral therapy
- Discuss current treatment challenges in HIV care as they relate to the aging HIV-infected population
- Design treatment strategies for tuberculosis in HIV-infected patients that consider current data on new drug regimens and recommendations
Conflicts of Interest
In the interest of maintaining the independence of its CME activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (ie, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships that they or their spouses or partners have had with commercial companies within the past 12 months. Any real or apparent conflicts of interest of those parties are resolved prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA CME activity.
Who Should Attend
This course is designed for physicians who are actively involved in the medical care of people with HIV infection, specifically those who:
- Have a solid, working knowledge of HIV disease management
- Provide comprehensive or specialty care for patients with HIV infection
- Are currently active in HIV research
This activity is also relevant for other practitioners including nurse practitioners, nurses, physician assistants, pharmacists, and others.
Representatives and employees of commercial companies (pharmaceutical, diagnostic, medical products, advertising, insurance, investment, communications firms, etc) must contact the IAS–USA regarding registration procedures.
Cancellation and substitution requests must be made 8 or more days before the date of an activity. All refunds will be processed a week after the course minus a $15.00 processing charge. Regrettably, any cancellation requests received within a week before the course will not be eligible for the partial refund.
Continuing Education Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 7.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Academy of Family Physicians Credits
This Live activity, 22nd Annual Improving the Management of HIV Disease Advanced CME Course, with a beginning date of May 2, 2014, has been reviewed and is acceptable for up to 7.00 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Educational Review Systems is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/Commission on Accreditation. Provider # 5-115. This program is approved for 7.5 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California, the state of Florida and the District of Columbia.
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmaceutical education. This program is approved for 7.5 hours (0.75 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
ACPE # 0761-9999-14-059-L01-P
This course is funded through independent, educational grants at a national level from commercial organizations that are committed to supporting high-quality continuing medical education (CME). This activity is part of a national effort that includes this and other live CME courses, live course webcasts, live webinars, Cases on the Web, and Topics in Antiviral Medicine.™ In the interest of an objective, unbiased, balanced, and scientifically rigorous program, the IAS–USA seeks and pools funding from companies with competing products to support the program. These companies have no input into or control over the program content or the selection of faculty. We gratefully acknowledge the support of the companies listed below.
Merck & Co, Inc
Gilead Sciences, Inc
Salix Pharmaceuticals, Inc